» Articles » PMID: 38758809

Interventions to Mitigate Cancer-related Medical Financial Hardship: A Systematic Review and Meta-analysis

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2024 May 17
PMID 38758809
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study systematically reviewed interventions mitigating financial hardship in patients with cancer and assessed effectiveness using a meta-analytic method.

Methods: PubMed, Cochrane, Scopus, CINAHL, and Web of Science were searched for articles published in English during January 2000-April 2023. Two independent reviewers selected prospective clinical trials with an intervention targeting and an outcome measuring financial hardship. Quality appraisal and data extraction were performed independently by two reviewers using a quality assessment tool. A random-effects model meta-analysis was performed. Reporting followed the preferred reporting items for systematic review and meta-analyses guidelines.

Results: Eleven studies (2211 participants; 55% male; mean age, 59.29 years) testing interventions including financial navigation, financial education, and cost discussion were included. Financial worry improved in only 27.3% of 11 studies. Material hardship and cost-related care nonadherence remained unchanged in the two studies measuring these outcomes. Four studies (373 participants; 37% male, mean age, 55.88 years) assessed the impact of financial navigation on financial worry using the comprehensive score of financial toxicity (COST) measure (score range, 0-44; higher score = lower financial worry) and were used for meta-analysis. There was no significant change in the mean of pooled COST score between post- and pre-intervention (1.21; 95% confidence interval, -6.54 to 8.96; p = .65). Adjusting for pre-intervention COST, mean change of COST significantly decreased by 0.88 with every 1-unit increase in pre-intervention COST (p = .02). The intervention significantly changed COST score when pre-intervention COST was ≤14.5.

Conclusion: A variety of interventions have been tested to mitigate financial hardship. Financial navigation can mitigate financial worry among high-risk patients.

Citing Articles

Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach.

Jones S, Ohlsen T, Karvonen K, Sorror M Blood Adv. 2024; 8(19):5146-5155.

PMID: 39146495 PMC: 11470286. DOI: 10.1182/bloodadvances.2024012998.

References
1.
Hamel L, Dougherty D, Hastert T, Seymour E, Kim S, Assad H . The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication. PEC Innov. 2023; 1:100002. PMC: 10194252. DOI: 10.1016/j.pecinn.2021.100002. View

2.
Witte J, Mehlis K, Surmann B, Lingnau R, Damm O, Greiner W . Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol. 2019; 30(7):1061-1070. PMC: 6637374. DOI: 10.1093/annonc/mdz140. View

3.
Watabayashi K, Steelquist J, Overstreet K, Leahy A, Bradshaw E, Gallagher K . A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers. J Natl Compr Canc Netw. 2020; 18(10):1366-1373. DOI: 10.6004/jnccn.2020.7581. View

4.
Su C . Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary. JCO Oncol Pract. 2022; 18(9):607-609. PMC: 9509202. DOI: 10.1200/OP.22.00357. View

5.
Sidik K, Jonkman J . A note on variance estimation in random effects meta-regression. J Biopharm Stat. 2005; 15(5):823-38. DOI: 10.1081/BIP-200067915. View